For most people, Peak Wellness is cheaper
Level 2 Injections Lipo-Slim: A blend of essential B vitamins with MIC (amino acids methionine, inositol, and choline) help the liver process fat more effectively, increase energy, and aid in stress management
GIP and GLP-1: Incretin hormones with unique biological activities
short 2.5 mg cohort about -4.7% at ~4 weeks, -12.7% by the 5 mg phase (Barrea 2026): Mody Diabetes Ther 2025
Effects on intestinal epithelial barrier integrity, mucin expression, and gut motility have all been documented
(2021), Lancet 397(10286), PubMed 33894838 Statistics from preclinical literature Cagrilintide (development code AM833 ), a long-acting amylin analogue , 32 amino acids, molecular weight 3.795 kDa Developed at Novo Nordisk (Denmark) as part of the CagriSema combination program (cagrilintide + semaglutide) Target: amylin receptors (AMY1, AMY2, AMY3) + secondarily the calcitonin receptor , extended half-life via a C16 fatty acid linker Standard dose in clinical trials: 0.164.5 mg/week subcutaneously (Phase 1b/2) Phase 2 (Enebo 2021, n=96): 17.1 % reduction in body weight with CagriSema 2.4 mg + 2.4 mg over 20 weeks vs 9.8 % with semaglutide alone REDEFINE 1 Phase 3 (2024, preliminary data): 22.7 % weight reduction with CagriSema 2.4 mg/2.4 mg over 68 weeks Status: Phase 3 completed 20242025 , FDA filing expected 20252026 Approximately 25+ peer-reviewed publications in PubMed (20182024) Reference sources (PubMed) Enebo LB
